Key facts
- Codoxo’s last known valuation is $280.5M (Oct 2025).
- It has raised $67.1M across 1 recorded rounds; the latest was Early Stage VC ($5.2M) in Dec 2021.
- Notable investors include Service Provider Capital, QED Investors, Sands Capital, CVS Health Ventures, Echo Health Ventures — 22 tracked in total.
- Codoxo has filed 3 Form Ds with the SEC since 2022, most recently Oct 2023 ($5.2M sold to 4 investors).
- Status: Privately Held (backing).
Leadership
- Mustaque AhamadExecutive & Founder
- Toby ShumVice President
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Codoxo
Funding rounds
1 roundsAbout Codoxo
Developer of an generative artificial intelligence healthcare payment integrity platform designed to accelerate the identification of fraud, waste, and abuse in healthcare plans. The company's platform offers comprehensive capabilities span across provider education, data mining, clinical chart and medical record reviews, no-code concept ideation, fraud detection, audit workflow and case management and provider contract and medical policy compliance, enabling investigators and analysts to identify and prevent payment errors before claims are even submitted, stopping issues at earliest intervention point.
- Sector
- Healthcare
- HQ
- Duluth, GA, United States
- Founded
- 2016
- Employees
- 88
- Website
- codoxo.com/
- Ownership
- Privately Held (backing)
Codoxo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Codoxo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Codoxo in its N-PORT filings yet. We sweep new filings monthly.